Filing Details

Accession Number:
0000711377-18-000051
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-19 12:19:21
Reporting Period:
2018-11-15
Accepted Time:
2018-11-19 12:19:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Executive Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-11-15 10,000 $29.71 746,484 No 4 M Direct
Common Stock Disposition 2018-11-15 10,000 $62.01 736,484 No 4 S Direct
Common Stock Acquisiton 2018-11-15 15,335 $29.71 751,819 No 4 M Direct
Common Stock Disposition 2018-11-15 15,335 $62.73 736,484 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2018-11-15 10,000 $0.00 10,000 $29.71
Common Stock Common Stock (Right to Buy) Disposition 2018-11-15 15,335 $0.00 15,335 $29.71
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
317,436 2019-10-31 No 4 M Direct
302,101 2019-10-31 No 4 M Direct
Footnotes
  1. Options were granted on 10/1/204, have five year lives, and vest in equal 205 annual installments on each of the first five anniversary dates following the grant